Found: 16
Select item for more details and to access through your institution.
B Cell Kinetics upon Therapy Commencement for Active Extrarenal Systemic Lupus Erythematosus in Relation to Development of Renal Flares: Results from Three Phase III Clinical Trials of Belimumab.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 22, p. 13941, doi. 10.3390/ijms232213941
- By:
- Publication type:
- Article
Early B Cell and Plasma Cell Kinetics Upon Treatment Initiation Portend Flares in Systemic Lupus Erythematosus: A Post-Hoc Analysis of Three Phase III Clinical Trials of Belimumab.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.796508
- By:
- Publication type:
- Article
COVID-19 Vaccination-Related Delayed Adverse Events among Patients with Systemic Lupus Erythematosus.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 24, p. 7542, doi. 10.3390/jcm12247542
- By:
- Publication type:
- Article
Current Insights on Biomarkers in Lupus Nephritis: A Systematic Review of the Literature.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 19, p. 5759, doi. 10.3390/jcm11195759
- By:
- Publication type:
- Article
Biomarkers in Neuropsychiatric Systemic Lupus Erythematosus: A Systematic Literature Review of the Last Decade.
- Published in:
- Brain Sciences (2076-3425), 2022, v. 12, n. 2, p. 192, doi. 10.3390/brainsci12020192
- By:
- Publication type:
- Article
Serum profiling identifies CCL8, CXCL13, and IL-1RA as markers of active disease in patients with systemic lupus erythematosus.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1257085
- By:
- Publication type:
- Article
Patients with NPSLE experience poorer HRQoL and more fatigue than SLE patients with no neuropsychiatric involvement, irrespective of neuropsychiatric activity.
- Published in:
- Rheumatology, 2024, v. 63, n. 9, p. 2494, doi. 10.1093/rheumatology/keae216
- By:
- Publication type:
- Article
Determinants of neuropsychiatric flares in patients with systemic lupus erythematosus: results from five phase III trials of belimumab.
- Published in:
- Rheumatology, 2024, v. 63, n. 3, p. 798, doi. 10.1093/rheumatology/kead249
- By:
- Publication type:
- Article
Sensitivity analysis of EQ-5D-3L index scores in terms of discriminative and known-groups validity in SLE: introducing Adequate Health State.
- Published in:
- Rheumatology, 2023, v. 62, n. 12, p. 3916, doi. 10.1093/rheumatology/kead140
- By:
- Publication type:
- Article
Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study.
- Published in:
- Rheumatology, 2023, v. 62, n. 7, p. 2453, doi. 10.1093/rheumatology/keac661
- By:
- Publication type:
- Article
COVID-19 vaccination in autoimmune diseases (COVAD) study: vaccine safety and tolerance in rheumatoid arthritis.
- Published in:
- Rheumatology, 2023, v. 62, n. 7, p. 2366, doi. 10.1093/rheumatology/keac624
- By:
- Publication type:
- Article
Impact of remission and low disease activity on health-related quality of life in patients with systemic lupus erythematosus.
- Published in:
- Rheumatology, 2022, v. 61, n. 12, p. 4752, doi. 10.1093/rheumatology/keac185
- By:
- Publication type:
- Article
EQ-5D-3L full health state discriminates between drug and placebo in clinical trials of systemic lupus erythematosus.
- Published in:
- Rheumatology, 2021, v. 60, n. 10, p. 4703, doi. 10.1093/rheumatology/keab080
- By:
- Publication type:
- Article
Contribution of abnormal BMI to adverse health-related quality of life outcomes after a 52-week therapy in patients with SLE.
- Published in:
- Rheumatology, 2021, v. 60, n. 9, p. 4205, doi. 10.1093/rheumatology/keaa909
- By:
- Publication type:
- Article
Breakthrough SARS-CoV-2 infection in fully vaccinated patients with systemic lupus erythematosus: results from the COVID-19 Vaccination in Autoimmune Disease (COVAD) study.
- Published in:
- Rheumatology International, 2024, v. 44, n. 10, p. 1923, doi. 10.1007/s00296-024-05682-6
- By:
- Publication type:
- Article
Neuropsychiatric involvement in systemic lupus erythematosus contributes to organ damage beyond the nervous system: a post-hoc analysis of 5 phase III randomized clinical trials.
- Published in:
- Rheumatology International, 2024, v. 44, n. 9, p. 1679, doi. 10.1007/s00296-024-05667-5
- By:
- Publication type:
- Article